AbbVie (ABBV) Announces FDA Approval of VUITY 1.25%, the First and Only Eye Drop to Treat Presbyopia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. SPY
9. EVMN
10. DYN

Go back to AbbVie (ABBV) Announces FDA Approval of VUITY 1.25%, the First and Only Eye Drop to Treat Presbyopia
AbbVie (NYSE: ABBV) Delayed: 249.38 +0.60 (0.24%)
Previous Close $248.78    52 Week High $68.12 
Open $247.73    52 Week Low $50.71 
Day High $249.55    P/E 54.10 
Day Low $246.77    EPS $4.61 
Volume 159,459